biosimilar drug Archives | Be Korea-savvy

Home / Posts tagged biosimilar drug

Sandoz Inaugurates New Antibiotic Production Plant in Austria and New Biosimilar Development Center in Germany

Investment of EUR 175 million reaffirms Sandoz commitment to long-term leadership in off-patent medicines New penicillin production process will significantly improve ecological footprint and help secure European-based supply Cutting-edge development hub will play key role in supporting long-term growth of leading biosimilar business Basel, November 10, 2023 (Korea Bizwire) – Sandoz, the global leader in generic [...]

Samsung Bioepis Gets Nod for Sale of Ophthalmology Biosimilar Drug in Europe

SEOUL, Aug. 23 (Korea Bizwire) — South Korean biopharmaceutical firm Samsung Bioepis Co. said Monday it has won approval from European authorities for the sale of its ophthalmology biosimilar, Byooviz. The European Commission granted the marketing authorization on ranibizumab biosimilar, previously known as SB11, which references Swiss pharmaceutical giant Novartis’ blockbuster medication Lucentis. It is [...]

Samsung Bioepis Gets Nod for Sale of Anticancer Biosimilar Drug in Europe

SEOUL, Aug. 21 (Korea Bizwire) — South Korean biopharmaceutical firm Samsung Bioepis Co. said Friday it has won approval from European authorities for the sale of its anticancer biosimilar drug, Aybintio. The European Commission (EC) accepted Samsung Bioepis’ application to sell the bevacizumab biosimilar, also known as SB8, which references Switzerland-based Roche Holding’s blockbuster pill [...]